Crea Aortic Valve study for severe aortic stenosis
Part of Heart & circulation clinical trials.
This study tests a new valve called the Crea Aortic Valve, placed through a catheter (TAVR), for people with severe aortic stenosis who are at high risk for open-heart surgery. The goal is to see if the valve is safe and works well in the real world.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You're 60 years or older.
- You have severe aortic valve stenosis (a narrowed valve causing symptoms).
- Your heart team says you need a TAVR procedure (valve replacement through a catheter).
- You're considered too high-risk for open-heart surgery.
- No active infections or heart infections (endocarditis).
- You agree to follow the study schedule and visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study checks whether an “investigational” transcatheter aortic valve is safe and works well for people with severe, calcified aortic stenosis (a stiff, narrowed heart valve). It may help improve valve function and symptoms, but you must meet specific heart, scan, and health-status requirements.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This study tests a new device called the RENATUS® Transcatheter Aortic Valve System for people with severe aortic stenosis. It is designed to replace the narrowed valve without open-heart surgery, and aims to see if it is safe and effective for patients with various surgical risk levels.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.